Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
$1.11B |
| 2 |
Charter Communications
CHTR
|
$592M |
| 3 |
Amazon
AMZN
|
$478M |
| 4 |
Sanofi
SNY
|
$414M |
| 5 |
Elanco Animal Health
ELAN
|
$388M |
Top Sells
| 1 |
Schlumberger
SLB
|
$1.16B |
| 2 |
ConocoPhillips
COP
|
$715M |
| 3 |
T-Mobile US
TMUS
|
$600M |
| 4 |
Microchip Technology
MCHP
|
$543M |
| 5 |
Goldman Sachs
GS
|
$425M |
Sector Composition
| 1 | Financials | 23.41% |
| 2 | Healthcare | 19.23% |
| 3 | Technology | 16.26% |
| 4 | Communication Services | 12.06% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Walt Disney
DIS
$213B
| $34.4M | 0.02% | 395,756 -25,365 | -6% | -$2.2M |
|
102
Eli Lilly
LLY
$657B
| $23.3M | 0.02% | 63,687 -6,007 | -9% | -$2.2M |
|
103
Travelers Companies
TRV
$61.1B
| $22.1M | 0.02% | 117,720 -4,055 | -3% | -$760K |
|
104
AstraZeneca
AZN
$248B
| $20.9M | 0.01% | 308,325 -78,040 | -20% | -$5.29M |
|
105
Merck
MRK
$210B
| $19.4M | 0.01% | 175,231 -14,100 | -7% | -$1.56M |
|
106
Target
TGT
$43.6B
| $19.3M | 0.01% | 129,692 -2,625 | -2% | -$391K |
|
107
Thermo Fisher Scientific
TMO
$186B
| $16.1M | 0.01% | 29,199 -1,830 | -6% | -$1.01M |
|
108
Procter & Gamble
PG
$368B
| $15M | 0.01% | 99,300 -700 | -0.7% | -$106K |
|
109
Halliburton
HAL
$19.4B
| $11.5M | 0.01% | 291,201 -90,100 | -24% | -$3.55M |
|
110
Walmart
WMT
$774B
| $10.9M | 0.01% | 77,180 -8,010 | -9% | -$1.14M |
|
|
HES
111
DELISTED
Hess
HES
| $9.8M | 0.01% | 69,132 -16,428 | -19% | -$2.33M |
|
112
Exxon Mobil
XOM
$487B
| $9.18M | 0.01% | 83,240 -1,020 | -1% | -$113K |
|
113
Home Depot
HD
$405B
| $8.99M | 0.01% | 28,467 -706 | -2% | -$223K |
|
114
Adobe
ADBE
$151B
| $8.43M | 0.01% | 25,046 -1,000 | -4% | -$337K |
|
115
APA Corp
APA
$8.31B
| $8.38M | 0.01% | 179,450 -66,023 | -27% | -$3.08M |
|
116
Caterpillar
CAT
$196B
| $7.2M | ﹤0.01% | 30,049 -1,388 | -4% | -$333K |
|
117
Pfizer
PFE
$141B
| $6.34M | ﹤0.01% | 123,685 -18,501 | -13% | -$948K |
|
118
Analog Devices
ADI
$124B
| $6.17M | ﹤0.01% | 37,602 -3,539 | -9% | -$581K |
|
119
Deere & Co
DE
$129B
| $5.33M | ﹤0.01% | 12,436 | – | – |
|
120
Boston Scientific
BSX
$156B
| $5.22M | ﹤0.01% | 112,890 -2,700 | -2% | -$125K |
|
121
IBM
IBM
$227B
| $5.19M | ﹤0.01% | 36,814 -1,200 | -3% | -$169K |
|
122
Vulcan Materials
VMC
$38.5B
| $4.59M | ﹤0.01% | 26,200 -1,300 | -5% | -$228K |
|
123
Danaher
DHR
$147B
| $4.57M | ﹤0.01% | 17,232 -910 | -5% | -$242K |
|
124
Synopsys
SNPS
$112B
| $4.38M | ﹤0.01% | 13,730 -1,754 | -11% | -$560K |
|
125
Amgen
AMGN
$155B
| $4.26M | ﹤0.01% | 16,207 | – | – |
|